Dexmedetomidine Versus Lidocaine in Attenuating Airway Reflexes During Recovery of Thyroidectomy Patients
Launched by AIN SHAMS UNIVERSITY · Dec 10, 2022
Trial Information
Current as of January 16, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is studying how well two different medications, Dexmedetomidine and lidocaine, can help reduce coughing and airway reflexes in patients recovering from thyroid surgery. Coughing after surgery can sometimes lead to complications like high blood pressure and bleeding, so the researchers want to find out which medication is more effective in making the recovery process smoother.
To participate in this study, patients must be between 18 and 65 years old and scheduled for elective thyroid surgery. They should be in good health (classified as ASA class I or II) and not have conditions like asthma or a current respiratory infection. If you join the study, you'll receive one of the two medications during your recovery, and the researchers will monitor how you respond. This trial is currently looking for participants, and your involvement could help improve care for future patients undergoing similar procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients scheduled for elective thyroidectomy surgery.
- • Age: patients between 18-and 65-years old from both sexes.
- • Classified as either American Society of Anesthesiologists (ASA) class I or II.
- Exclusion Criteria:
- • Refusal of procedure or participation in the study.
- • Patients suffering from asthma, chronic cough, preoperative upper respiratory infection symptoms.
- • Current smoker.
- • Medication involving angiotensin-converting-enzyme inhibitors (ACE-I).
- • Classified as either American Society of Anesthesiologists (ASA) class III or IV.
- • Sinus Bradycardia (\<60/min) or history of any type of heart block or Beta-Blockers medication.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials